| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |